Fingerprint
Dive into the research topics of 'Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity
Eric R. Crouch, Raymond T. Kraker, David K. Wallace, Jonathan M. Holmes, Michael X. Repka, Janine E. Collinge, Don L. Bremer, Michael E. Gray, Heather A. Smith, Paul G. Steinkuller
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations